News

Healthline21h
FDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
30 Walmart Products To Help With Those Human Things You Simply Can’t Control
Promising review: "It's a great size; heats up quickly, nice soft and pretty cover. The cord is nice and long so that if ...
US FDA approves Amneal's self-administered migraine treatment
The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals' self-administered migraine drug, giving way to a ...
New Biologics Reshape the gMG Landscape, but Growth Opportunities Persist for Established and Pipeline Therapies, According to Spherix Global
High rates of biologic naivety, limited switching, and ongoing unmet needs across the gMG landscape create opportunity for brand differentiation.EXTON, PA, May 15, 2025 (GLOBE NEWSWIRE) -- The ...
The American Journal of Managed Care11h
Rozanolixizumab for gMG Approved in Japan for Self-Administration
The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...
Le Lézard18h
Enteral Feeding Devices Market worth US$3,994.2 million by 2030 with 6.0% CAGR | MarketsandMarketstm
The global Enteral Feeding Devices Market, valued at US$ 2,796.3 million in 2024, is forecasted to grow at a robust CAGR of 6.0%, reaching US$2,965.1 million in 2025 and an impressive US$3,994.2 ...
Stocktwits on MSN18h
Amneal Gets FDA Nod For Self-Administrable Migraine Injection
Shares of Amneal Pharmaceuticals, Inc. (AMRX) traded marginally higher on Thursday morning after the U.S. Food and Drug ...